Index of artpub/2024/308075/

Abrisqueta, Pau
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL) : GELLC-7 trial from the Spanish group of CLL (GELLC)
2024
https://ddd.uab.cat/record/308075